Stock Market Investing Strategies November 16. 2015

Stock Market Investing Strategies

Stock Market Investing Strategies 

Read the Stock Market Investing Strategies November 16, 2015 Newsletter in .pdf fomat – Click Here

Stock Market Investing Strategies

November 16, 2015

Sample Issue

 Balanced Investing Strategies To Make Money In Up Or Down Markets


A Publication of Princeton Research, Inc. (

Contributing Staff: Michael King, Charles Moskowitz


Where To Invest In 2015 Newsletter Covering:

Where to Invest November 2015

Best Stocks To Buy November 2015

Stock Market Investing Strategies

Stock Options Trade Alerts

Options Trading Strategies

How To Trade Options


2015 YTD Profits $ 8144

Over 81% Returns


2014 Profits = $ 20,443

Over 204% Returns


Options Trading Alerts  


NOTE: This is a Sample Issue Only!






For Free Where To Invest Your Money Now

High Return Investments Trade Alerts

Go To:



$10,000 Trading Portfolio
Charles Moskowitz Discussion


We Have 3 Long Open Positions:


PFE Dec 34 Calls

TLT Dec 119 Calls and

UAL Dec $ 62.50 Calls


Funds in Use = $1,236


The losses on NE and TWTR were actually the second half of trades from the week before that were taken out on the 100% Up rule.  This left us with overall profits in both trades.  Funds in use are $1236.


The attacks in Paris should generate some well- deserved anxiety and along with that generally comes international purchases of Gold and some of the miners.  As Mike points out in the Fundamental section later in this letter, this is also a time of the year for a rally in the metals.  I will determine the best way to trade the gold or silver after I see what the futures are doing overnight.


The Democratic debate was kind of a nonevent.  To me, it differs dramatically from the Republicans in that they may have to go with someone other than Jeb Bush.  I am really surprised at his lack of ability to take any aggressive stand on the issues.  I can’t believe that Trump or Carson have any real shot at the nomination, but the overall suspension of what we have come to know as a political belief favors an outsider.  Let’s hope something changes soon…


Early in the week we went long the bonds (TLT) and it seems to be working.  I was on this side of the market when nobody else could see anything but higher rates back In November of last year.  Technically we had a temporary top around 152 (Dec 30-yr Contract) after a rally from 142.  We than had pullback and then we broke out to a massive move to 166 in just 3 weeks.


I have said repeatedly that these are moves that used to take months or years, but these markets are no longer bound by time.  After coming back down to consolidate in the 148-152 area we had several closes all around that magic number..152.  Three weeks ago I said that if we broke 156 we would test 152, and this area again looks to me to be very important.  If the trend line beginning in January 2014 holds we could see a test of 156 or higher.


The political issues tend to cause a flight to safety in both Gold and US treasuries.  We are already long the bonds and we will look for the gold trade early in the week…..CAM



Market Strategies $10,000 Trading Account Trade Table

11/10 Sold 6 ETSY December 10 Calls 0.50         300        120 Loss
11/10 Bought 6 PFE December 34 Calls 0.92   552
11/10 Sold 5 NE November 14 Calls

( 50% Loss Rule)

0.25         125        120 Loss
11/09 Bought 4 TLT December 119 Calls 1.72   688
11/09 Bought 6 TJX December 75 Calls 0.95   570         504          66 Loss
11/09 Bought 4 UAL December 62.50 Calls 1.89   756
11/09 Sold 8 SUN December 40 Calls

( 50% Loss Rule )

0.37         296        304 Loss
11/09 Sold 3 TWTR December 30 Calls 0.78         234        168 Loss
11/04 Bought 6 ETSY November 10 Calls 0.70   420
11/02 Sold 5 NE Nov 14 Calls

( 100% Profit Rule )

0.98         490        245 Gain
11/02 Bought 10 NE November 14 Calls 0.49   490
10/28 Sold 3 TWTR December 30 Calls

( 100% Profit Rule ) Three lots remain Open

2.68         804        402 Gain
10/28 Bought 6 TWTR December 30 Calls 1.34   804
10/21 Bought 8 SUN December  40 Calls 0.75   600


Remember, these trades are based on your participation in the

Subscriber Members Only



Previous closed out trades not listed here may be seen in previous market letters in the

VIP Subscribers Members Area.


For Free Where To Invest Your Money Now

High Return Investments Trade Alerts

Go To:

Where To Invest options trading news


MARKET Laboratory – Weekly Changes


Prices are copied from Barron’s Weekly and Yahoo Finance and may be incorrect.









S&P 500








Russell 2000








Gold (spot)












Heating Oil




Unleaded Gas




Natural Gas








Put/Call Ratios

S&P 100



Put/Call Ratios

CBOE Equity





153-12 +1-02

3.06% -0.03%

10 Yr. Note

126-17+156         2.28%-0.05%






CRB Inflation





Barron’s* Confidence







5 Yr. Note

119-02 +116

1.66% -0.07%






DJ Utilities








Long Term



34.3 %














M1 Money  Supply


Nov 2nd

M-2 Money



Nov 2nd



* Component Change in the Confidence Index


M1…all money in hands of the public, Time Deposits Traveler’s Checks, Demand Deposits
M2.. adds Savings and Money Market Accounts both compared with the previous year.

Where To Invest Your Money Now

Market Strategies Technical Information


                              Support/Resistance Levels:                SUPPORT                         RESISTANCE


S&P 500             1997                                   2049

Dow                 17,045                                 17,488

QQQ            107.10                                 110.90

Transports        79.79                                   8207

NASDAQ           4829                                5028




$100,000 Trading Portfolio Stock Positions and Trades

Each stock is allocated a theoretical $ 5,000 share of the portfolio unless otherwise indicated.  




Purchase Price Purchase Date Stop/Loss   Price/Date Sold   Profit/
SPXU   100 30.08       11/02
TWTR  200 28.51       10/28
SPXU  200 34.10       10/15
CUBA   500   7.58       09/28
MOS  100 43.55       08/14
CRM  100 72.90       04/29      66.25
NBG  600 1.40       02/17
BAC. Wts 5,000 lots 0.7411       12/26
BSBR  500






SAN  600 8.40      12/16
AA  500 14.21      10/16
FCX 150 34.99      09/09    7.75
NBG 300   2.95      05/19
NBG 300 4.08 8/12
TEXQY* 200 6.56 7/11
REPR* 5000 0.22 10/22/12

Remember, these trades are based on your participation in the

Subscriber Members Only


Previous closed out trades not listed here may be seen in previous market letters in the

VIP Subscribers Members Area.


For Free Where To Invest Your Money Now

High Return Investments Trade Alerts

Go To:

For those of you who do not buy puts to protect your portfolio, there are many ETF’s that are the inverse of the DOW. The symbols are DOG, DXD, SDS,TZA and RWM, which go up when the  DOW, S&P 500 and Russell 2000 go down and down when they go up. The DZZ goes up double when gold goes down.

Balanced Investing Strategies


Market Strategies $100,000 Trading Account

New Options Trades:

New Trades will be Texted


There were five closed option positions all at a loss:


The remaining 10 NE Nov 14 Calls were sold on the 50% Loss Rule losing $ 240

The 16 SUN Dec 40 Calls lost $ 304, also sold on the 50% loss Rule.

The ETSY December 10 Calls were sold on Nov 10th at $ 0.50  losing $ 240.

The TWTR Dec 30 Calls were sold on Nov 9th losing $ 336

while the TJX Calls sold on the 10th lost $ 132.


The options total for the week showed a loss of $ 1,612.


There were no closed out stock positions:


For the year to date we have gains of $ 21,907. 


Open position losses in the stock account increased by $ 1,813 to $ 16,109.


The options expire on the third Friday of each Month unless otherwise posted.


The Stock table has the following 17 positions:





The options call for a $ 2,500 investment unless otherwise stated; each stock position requires $5,000 unless otherwise mentioned specifically.


We are basing money management on a hypothetical

$ 100,000 and are using a total of

$   61,721 for the 17 open stock positions. There are two long option positions requiring

$     2,480 which added to the stock longs totals an outlay of

$   64,201 leaving

$   28,402 in cash.


The two long open options positions in the table below are: 12 PFE and 8 TLT Calls.


These figures are approximate and there might be errors.


We have not counted the dividends received from Apple, JP Morgan, North American Tankers, Santander, their Brazil affiliate BSBR and Blue Capital Reinsurance which was sold for a profit and many others.


Executions that have occurred at or near the open or close of trading sometimes vary from our actual numbers.  For example, when something opens down and it is through our price, we take the next trade whether it is an uptick or continues lower.  This sometimes results in a 50% trade that is slightly above or below the exact number.


Balanced Investing Strategies

Previous Week’s Recommendations and

Rules for the Market Strategies

$100,000 Portfolio Trading Account


  • All options count for about $ 2,500.00 for model portfolio calculations unless

otherwise stated


  • When the option has doubled sell half the position


  • Stop Loss protection is either half or offered with each trade


  • The cost of the option is the asking price (or the price between the bid and ask,

whichever is more realistic)


  • The options will be followed until closed out.


  • Option Symbols are stock symbol with expiration month and strike price


Option Cost Date Sold Date Profit/


PFE Dec 34

12 lots



TLT Dec 119

8 lots



TJX Dec 75

12 lots



11/09/15 0.84 11/10/205 ( $ 132 )
ETSY Nov 10

12 lots



11/04/15 0.50 11/10/2015 ( $ 240 )
UAL Dec 62.50

8 lots



NE Nov 14

20 lots

10 lots Open



11/02/15 0.98

Sold Half 100% Profit Rule



Sold Balance





$ 490



( $ 240 )

TWTR Dec 30

6 lots Open



10/28/15 2.68

Sold Half 100% Profit Rule



Sold Balance





$ 804



( $ 336 )

SUN Dec 40

16 lots



10/21/15 0.37

50% Loss Rule

11/09/2015 ( $ 608 )
SPXU Nov 33

Closed out



10/16/15 0.26

Debit against long



$ 410

( $ 52 )


Remember, these trades are based on your participation in the

Subscriber Members Only




Previous closed out trades not listed here may be seen in previous market letters in the

VIP Subscribers Members Area.



For Free Where To Invest Your Money Now

High Return Investments Trade Alerts

Go To:


Where To Invest Now September 2015

This Weeks’ Economic Numbers

Earnings Releases and Media Data


Before the Open on top of the Row;

After the close below the Economics Information


MONDAY JD ( 0.12 vs -0.12 ) Fuel Systems Solutions FSYS ( -0.09 vs -0.16 )

08:30 hrs Empire Manufacturing Nov ( NA vs -0.2% )


Agilent A ( 0.47 vs 0.88 ) Urban Outfitters URBN ( 0.42 vs 0.35 ) Nuance Communications NUAN ( 0.35 vs 0.33 ) Mathews MATW ( 0.89 vs 0.82 )

TUESDAY Dick’s Sporting Goods DKS ( 0.47 vs 0.41 ) Home Depot HD ( 1.12 vs 1.15 )

Wal-Mart WMT ( 0.98 vs 1.15 ) JA Solar JASO ( 0.24 vs 0.21 ) TJX TJX ( 0.85 vs 0.85 ) Cheetah Mobile CMCM ( 0.21 vs 0.43 ) ReneSola  SOL ( -0.2 vs -0.12 )

08:30 hrs CPI Oct  ( NA vs -0.2% )

08:30 hrs CORE CPI   ( NA vs +0.2% )

09:15 hrs Industrial Production  Oct  ( 0.1% vs -0.2% )

Capacity Utilization ( NA vs 77.5% )

10:00 hrs NAHB Housing Market Index 11/14 ( NA vs 64 )

16:00 hrs Net Long Term TIC Flows Sept ( NA vs +$ 20.4Bln )

Jack In The Box  JACK ( 0.65 vs 0.54 ) Vipshop VIPS  ( 0.12 vs 0.08 )

WEDNESDAY Lowe’s LOW ( 0.78 vs 0.59 ) Staples SPLS 0.35 vs 0.37 Target TGT 0.86 vs 0.54

07:00 hrs  MBA Mortgage Index  11/14   ( NA vs -1.3% )

08:30 hrs  Housing Starts  Oct  (  NA vs 1206K  )

Building Permits ( NA vs 1103K  )

10:30 hrs  Crude Inventories 11/14  ( NA vs 4.22 Mln Bbls )

14:00 hrs  FOMC Minutes 10/28

Keurig Green Mtn GMCR ( 0.71 vs 0.90 ) L Brands JB ( 0.52 vs 0.44 ) Fidelity and Guarantee Life FGL ( 0.52 vs 0.48 ) CRM ( 0.19 vs 0.14 )  Hillenbrand HL( 0.55 vs 0.61 ) NetApp NTAP ( 0.56 vs 0.70 )Weibo WB 0.06 vs 0.01

THURSDAY Best Buy BBY ( 0.35 vs 0.32 ) Dillard’s DDS ( 1.20 vs 1.30 ) Gordmans Stores GMAN ( -0.13 vs -0.1 0 ) J M Smucker SJM ( 1.51 vs 1.53 ) Jinko Solar Holding JKS ( 0.81 vs 1.36 ) Kirklands KIRK ( 0.04 vs 0.07 ) Sears Holdings SHLD -2.84 vs -2.71

08:30 hrs Initial Claims 11/14  ( 269K vs  276K )

08:30 hrs Continuing Claims 11/07 ( 2155K vs 2155K )

08:30 hrs Philadelphia Fed  November ( NA vs -4.5 )

10:00 hrs Leading Indicators Oct  ( NA vs -0.2% )

10:30 hrs Natural Gas Inventories 11/14 ( NA vs   )

Gap GPS ( 0.63 vs 0.73 ) Intuit INTU ( -0.04 vs -0.10 ) Marvell MRVL 0.13 vs 0.29

Ross Stores ROST ( 0.50 vs 0.93 ) Williams-Sonoma WSM ( 0.73 vs 0.68 )

FRIDAY Abercrombie & Fitch ANF ( 0.23 vs 0.42 ) Foot Locker FL ( 0.94 vs 0.83 )

Hibbett Sporting HIBB ( 0.68 vs 0.67 ) Sirona Dental Systems SIRO ( 1.10 vs 0.93 )



Market Strategies Fundamentals

After making a seasonal high of 2116.48 on November 3rd the S&P 500 has slid seven of the past eight trading days to 2023.04, a decline of 4.4%. Last week alone it fell 3.63%. The Nasdaq, previously the leading index was the worst last week falling 4.26%, down 219.24 points to 4927.88. The Dow closed at 17,245 for a loss of 665 points or 3.7% while the Russell 2000 fell 53 points or 4.43% to 1146.55. Meanwhile, the DJ Transportation average was the best acting of all the misery down the least, 2.80% holding at 8010 off 231 points.

Top line revenues have not kept up with even lackluster earnings which together with the election year typical weakness could cause concern as the market seeks another support level. Crude oil prices collapsed 8% last week which makes a decline of more than 16% for the month of November.

Treasuries rallied on weak economic data, a dovish ECB and plummeting oil prices. Economic data continued very weak exacerbated by an extension of the two-week sell off in the stock market. Retail Sales, Core Retail Sales, the PPI and the Core PPI all missed expectations. The possibility of a deposit rate cut at the European central Bank’s December meeting also rose after comments from ECB President Mario Draghi last Thursday. The 10-year German Bund fell 14 basis points.

With the world bent on low rates and stocks in the doldrums, it appears to be the perfect time to buy Gold futures or just the GLD ETF. ( GLD: $ 103.55 ) The GLD November 20th 103 Call expires next Friday the 20th.It closed at 1.22. The December 18th 103 Call closed at 2.42 and that is the option we are recommending. Charles will put a trader’s touch to it.                                                                                                                                           

Gold prices tend to move up prior to the holidays, and the trend has worked especially well over the last 15 years. Seasonally speaking, it is best for traders to go long about now up to about November 18 and hold until about December 3. Over the last 40 years, this trade has worked 22 times for a success rate of 55.0% .The cumulative profit tallies up to $25,990. Up until two years ago this trade had been profitable for 12 straight years (2000-2011). The longer-term history of this trade is not as good, nonetheless profitable. Gold has had another tough year, but this is a short-term trade and gold has become oversold and appears ready for a bounce.


Market Strategies Economic Data

Retail sales were up a weaker than expected 0.1% ( consensus 0.3%), while sales, excluding autos, were up a weaker than expected 0.2% ( consensus 0.4%). Results for September were revised lower with total sales unchanged (from 0.1%) and sales excluding autos revised to -0.4% (from -0.3%).Gasoline station sales declined 0.9%, auto and parts sales fell 0.5%, electronics and appliance store sales were down 0.4%, and food and beverage store sales were down 0.3%. Clothing and clothing accessories sales were flat after declining 0.1% in August.

Core retail sales, which exclude auto, gasoline station, and building material and supplies sales, were up 0.3% in October after being flat in September. Core retail sales factor into the goods component for personal consumption expenditures in the GDP report, so there is a little bit of good news here

The increase in retail sales trailed the robust 0.6% increase in aggregate earnings seen in the October employment report, suggesting consumers continue to show a propensity to save money and/or pay down debt versus spending it more liberally on goods.

Retail Sales 0.1% 0.0% 0.0% 0.8% 0.0%
    Excluding Autos 0.2% -0.4% -0.1% 0.6% 0.4%
  Durable goods
    Building Materials 0.9% -0.3% -1.1% 3.7% -0.2%
    Autos/parts -0.5% 1.7% 0.3% 1.5% -1.6%
    Furniture 0.4% 0.6% -0.1% 0.9% -1.0%
  Nondurable goods
    General Merchandise -0.4% -0.1% 0.4% 0.2% 0.7%
    Food -0.3% -0.1% 0.4% 0.0% 0.1%
    Gasoline stations -0.9% -4.0% -2.2% -1.0% 1.2%
    Clothing 0.0% -0.1% -0.1% 0.3% -0.9%
    e*retailing/non-store 1.4% 0.3% 0.0% 1.5% 0.3%


The preliminary reading for the University of Michigan Consumer Sentiment Index for November showed an uptick to 93.1 from the final reading of 90.0 for October and 88.8 in the same period a year ago. The consensus expected a reading of 92.0. The improvement in November was driven by higher readings for both the Current Economic Conditions Index (to 104.8 from 102.3) and the Index of Consumer Expectations (to 85.6 from 82.1).

According to the chief economist for the survey, the overall increase was attributed to a stronger outlook for the domestic economy, which was fed by consumers anticipating somewhat larger income increases in 2016 and a somewhat lower inflation rate.

It was noted separately that buying plans for large discretionary items, especially vehicles, improved.

Consumer sentiment has little influence on consumption. As long as payroll levels continue to expand, the resulting income growth should keep consumption gains steady regardless of the monthly ebbs and flows in sentiment.

Sentiment 93.1 90.0 87.2 91.9 93.1
  Outlook 85.6 82.1 78.2 83.4 84.1
  Present conditions 104.8 102.3 101.2 105.1 107.2



Market Strategies Cycles

Since the late September bottom, and shortly thereafter the Stock Traders’ Almanac Seasonal MACD Buy Signal emerged on October 5 and  the market had vaulted higher. DJIA, S&P 500 and NASDAQ all reclaimed their respective 50- and 200-day moving averages. Today’s declines made a complete reversal putting the DJIA and S&P 500 back below their 200-day moving averages (solid red line in charts below). NASDAQ remains around 1% above its 200-day moving average. Stochastic, relative strength and MACD indicators have all plunged in the past few trading sessions, confirming the loss of upward momentum.


After a brief respite, the usual suspects of headwinds have reemerged. Greece, Puerto Rico very weak earnings and huge oil supplies are back in the headlines accompanied by the Fed’s desire to raise rates which in turn triggered the dollar to strengthen somewhat and commodities to stumble again. It still remains to be seen if the Fed will actually raise rates at its December meeting. Geopolitical events concerning the Isis and Europe have become an increasing headwind.  The issue of the Fed is becoming a back-seat event to more troubling problems. Whether or not the Fed actual has to raise rates is still an open discussion, but if they did, it would remove one large uncertainty that has held the market in check for the better part of a year. At which point, it would not be surprising to see the market make another run at record highs sometime in Q1 or early Q2 2016.


Recent research suggesting a tepid November is being confirmed by the market this week. Following this year’s big October gain early November strength has faded and the market is likely to stumble along into December. Pre-election Novembers are also historically weak. With this in mind, the majority of positions in the portfolio are on hold for now. The market may provide a more attractive buying opportunity in coming weeks.



For Free Where To Invest Your Money Now

High Return Investments Trade Alerts

Go To:



Undervalued Small Cap Stocks


Lower Priced stocks that look to be a buy:


Repro-Med Systems, Inc ( OTCQX:  REPR 0.36 )* 


REPR  is now a member of the OTCQX, a leading U.S. Stock Exchange.


Repro-Med Systems is a unique U.S. manufacturer of proprietary and patented medical devices world-wide which maintains offices and manufacturing facilities in Chester, NY.  Principal products include the Freedom 60 Syringe Infusion System, RMS High-Flo Subcutaneous Safety Needle Sets and the RES-Q-VAC Medical Suctioning Pump. In addition to being regulated by the FDA which has the authority to approve medical devices for marketing in the U.S., RMS complies with ISO International standards for quality development and manufacturing. RMS Medical Products is a d/b/a of Repro-Med Systems, Inc which was founded in 1980.


The Freedom60 has a proprietary technology that makes it desirable for the delivery of medications in a variety of therapies.  It is very popular for the delivery of subcutaneous immunoglobulin for the treatment of primary immune deficiency disease. The infusion pump uses “dynamic equilibrium” which safely adjusts the flow of medication in accordance with what the patient’s body can accept. This minimizes complications often encountered with other infusion systems which can lead to site reactions and discomfort for the patient. The portability and simple operation of the FREEDOM60 Improves quality of life for patients who otherwise might have to use a complicated electronic pump mounted to a cumbersome infusion pole. Patients then don’t have to be confined.


RMS High-Flo Subcutaneous Safety Needle Sets are being welcomed by healthcare providers and patients alike for their consistently high quality. The infusion sets are an ideal companion for the company’s FREEDOM 60 pump. The needle sets are patented and approved by the FDA. There has not been a new technology in needles other than Repro Med’s vastly better needle sets in quite some time.


RES-Q-VAC is a hand-held suction pump used to clear a patient’s airway or for other purposes when reliable hospital quality suctioning is needed. It uses patented technology to protect users from airborne pathogens and spillage of suctioned material. It is used by emergency service personnel and other first responders, as well as in hospitals and other institutions. There also is a version for use by dentists. RES-Q-VAC is invaluable in the event  of disasters where power is lost because it doesn’t require electricity.


The Freedom 60 Syringe Infusion System is a method for administering medication through a small needle to the subcutaneous tissue, which is the fatty tissue just under the skin. Subcutaneous infusion allows medication into the vascular system more slowly. Combined with more frequent delivery this provides more consistent and stable blood levels. The elimination of large swings in these levels decreases side effects improving overall quality of life. RMS provides High-Flo needles to optimize liquid flow. Their smaller 26 gauge high flow needle flows at the same rate as the considerably larger 24 gauge needles, which are considerably less painful when entering the skin.

The Freedom 60 has had great success in Europe reflected in a huge sales increase of 47.8% first quarter 2015 up from same quarter 2014.


Repro-Med Systems, Inc has had an increase in sales each of the last four years. They finished the year of 2014 with $ 11.2 million in sales reflecting top line growth of  29% from 2013.In each of the previous two years they had a 12% increase in sales. The company has had at least $ 700 thousand of net income in each of the past four years and has no debt. The patented needle sets alone can give the company a huge growth potential. In my opinion, with new products coming on stream, the stock should trade between $ 3 and $ 8 in the next two years.



Enzo Biochem ( ENZ 3.92 ) Bought at our price of $ 2.78. 


This turbulent market has had an effect on the price of Enzo Biochem. The markets, in my opinion, have been in a rotating correction and in some instances, a bear market for some months. It appears that the cause of this is China but I am sure that there are other factors. If you remember the ‘flash crash” of 2010 the market correction was over quickly and those that held through that market decline profited handsomely over the years after the crash. I think that the market is giving us another chance to buy Enzo Biochem at a bargain price.


The Company’s fiscal year was over July 31. I would imagine the Quarter and Year results will be made available by mid-October. With the cash settlement in two litigations the cash position should show a major improvement. Top line revenues should also show an improvement. Depending on R&D expenses and litigation expenses the net loss should also show improvement. At today’s price of $2.90 the Company is valued at approximately $130 million and with revenues approaching $100 million or 1.3 times revenues.


The last Craig Hallum report had a fair value of Enzo’s business of $6 per share. When AmpiProbe is approved and into the market that number is projected at $14 per share. There is always risk in the market so the investment is not without risk but if held over time should deliver handsome profits off of today’s price. Items to look forward to by the end of the year would be litigation news and an AmpiProbe decision all of which should have a positive impact on the stock price.



ProtoKinetix, Incorporated ( PKTX: 0.09 8) 


ProtoKinetix ( trading at $ 0.0521 low and 0.0969 high on Friday has a huge upside potential. They are in collaboration with the James Shapiro laboratory at the University of Alberta. The sole intention of the collaboration is to develop a commercial product pipeline of therapeutic applications for the AAGP™ family of molecules.


Dr. Shapiro is presenting his work at a symposium in Australia tonight and we should see some reaction to his work…We will also try to have him give us an update to the story for our radio show in the next few weeks.


Professor James Shapiro is Professor of Surgery, Medicine and Surgical Oncology, and Director of the Clinical Islet Transplant Program and the Living Donor Liver Transplant Program at the University of Alberta in Edmonton, Canada. He has a busy hepatobiliary surgical practice in HPB oncology, and in liver and kidney-pancreas transplant surgery. His center carries out 80 liver transplants per year, and has done around 80 living donor liver transplants. The University of Alberta just celebrated their 1000th liver transplant.


Dr. Shapiro directs the largest clinical islet transplant program worldwide with almost 170 patients treated, and led the clinical team that developed the “Edmonton Protocol” – the first trial to achieve consistent 100% insulin independence in a series of islet-alone transplant recipients with Type 1 diabetes (published in the NEJM 2000). Before Dr. Shapiro’s trial, the success rate with islet transplantation was less than 8%. He led an international multicenter trial to replicate these findings in 9 international centers (published in NEJM 2006).


Over the last 32 months Dr. Shapiro and his team have been extensively testing the AAGP™ molecule in allogeneic transplants using  human islet cells as the model. As regenerative medicine is rapidly becoming adopted in the treatment of degenerative diseases, the protection of the transplanted cells, tissues, and organs is of paramount importance. Transplanted cells and tissues are subjected to extreme stress factors that, unless protected, could cause failure to graft or premature death. The success of the tests  conducted in Edmonton have demonstrated that AAGP™ has the potential to be widely adopted in many areas of regenerative medicine.


International Star, Inc. (OTC: “ILST”)


ILST  is pleased to announce that the company’s management team will host an Investor Presentation/Reception at the historic Golden Nugget in Las Vegas, NV on November 15, followed by a tour of the Van Deemen gold project outside of Kingman, Arizona on November 16.


Key topics for discussion will be the recently announced technical report/resource estimate, ongoing permitting efforts and financing. The management team will be available to meet with investors and answer questions regarding the project. At the mine tour, we will be fortunate to have Bud Hillemeyer, one of the original stake holders in the Van Deemen project in the 1980s and the 2010 recipient of prestigious PDAC Thayer Lindsley International Mineral Discoveries Award, speak to investors on his involvement with the Van Deemen project.


For additional details and to sign up for either the presentation or tour, visit Both events are free, however RSVP is required. Please note that space for the mine tour is limited, therefore your earliest confirmation is appreciated.


International Star CEO Michael Shea commented: “Management is excited to meet shareholders and potential investors and provide the opportunity to visit the Van Deemen gold project. Our goal is to demonstrate the viability of the project and management’s capability to bring the mine online. As CEO, my most important commitment is to build value for my shareholders.To this end ILST is aggressively expanding our shareholder base as well as working with the legal team to enact creative programs that will reward shareholders of record.”


About International Star: (



Fundamental Analysis Stocks To Buy with Stops

The HDGE had a huge rally last week up almost 5%. The HDGE is a buy  when the market goes into periods of weakness like the past week.  We recommended to buy last week a stop loss at 10.28. It is a hedge against some long positions.


We took sizable profits on the United Rentals URI. The Enzo Biochem ENZ has made sizeable gains. The Arcelor Mital, Deere , DSX and Sunoco were stopped out with relatively small losses.


We always use stops. Keep losses small.


We are long Southwest Air (LUV) at 30 and we bought Virgin Air (VA) at 32.20. Please check on the previous weekly market letters if there are questions.  . We are long in Diana Shipping at 6.60.  We are long Bank of America  at 15.65. and would use 15.02  as a stop loss . BAC looks to have made a double bottom at  the 14.63 area.


   Heavy Black italicized indicates Execution


Symbol Name Business Description PE P/S MV mln Price Buy Limit Stop Loss

Or sold

SUN Sunoco Retail Sale Fuels 14 0.26   3B  36.0  36.08 32.71x

stopped out

URI United Rentals Equipment Rental 8 1.13 15B 79.00 64.34 Sold at 79
DE Deere Farm and Construction equipment 13 0.84 26.3B 77.51 77.50 76.77x Stopped Out
KR Kroger Food Mfg and Processing 18 0.33 37B 36.05 36.76 33.40x
MT Arcelor Mittal Integrated Steel mining and manufacturing 16.8 0.14 11.10B   5.43 5.80 5.22x Stopped Out
INTC Intel Technology chips platforms processors 13.6 2.8 152.83B 32.11 30.48 29.50
VA Virgin Air Regional Airlines 7.2 1.0 1.5B 37.0 32.20 33;50
LUV Southwest Air Regional Airlines 16 1.15 22.6B 45.89 33 42.31sco
ENZ Enzo Biochem Life Sciences NA 1.35 134M  4.50 2.78 3.28x
BAC Bank of America Commercial Bank 10 2.02 165.3B 17.20 15.65sco 16.92x
HDGE Advisor Shares Ranger Bear ETF 10.78 11.04 X 11.00X
DSX Diana Shipping Dry Cargo Shipping N/A 3.7 611  6.21 6.60 5.90 Stopped Out


NOTE: This is a Sample Issue Only!






Rule 17B Attestations and Disclaimers


Princeton Research, Inc. has approximately 2,581,578 shares of AIVN both free and restricted and represents them for Investor relations. Princeton also has about 40,000 shares of TXGE. Princeton is paid $ 1,500 per month from RMS Medical Products. Princeton has bought 81,100 shares of RMS Medical Products. Princeton was paid $ 2,500 to write a report on Xinergy. Princeton has signed a contract with CBLI to be paid $ 2500 for July and August for investor relations. Princeton has been engaged by Target Energy. No contract is currently in place. Princeton was paid about 500,000 restricted shares of Leo Motors.


When there is no movement in penny stocks, even though there is none or very small losses, we will liquidate ( sold AIVN on stop ) even though we like the company, if money is needed for better opportunities.


We now believe REPR represents upside opportunity. The Target ADR trades at about $ 4.50 in U.S. vs 0.05 in Australia. Princeton owns 400,000 Australia shares and about 900 U.S. ADR’s.


Pursuant to the provisions of Rule 206 (4) of the Investment Advisers Act of 1940, readers should recognize that not all recommendations made in the future will be profitable or will equal the performance of any recommendations referred to in this e-mail issue. Princeton may buy or sell its free-trading shares in companies it represents at any time.




Please Direct All Inquiries To:


Mike King

(702) 650-3000


Charles Moskowitz

 (781) 826-8882


Princeton Research

3887 Pacific Street,

Las Vegas, Nevada 89121


Stock Market Investing Strategies